Correction: AUA Announces 2025 Distinguished Awards Recognizing Top Urologists
04. Dezember 2024 14:03 ET
|
American Urological Association
BALTIMORE, Dec. 04, 2024 (GLOBE NEWSWIRE) -- The American Urological Association (AUA) announced today the list of 2025 award recipients recognizing top urologists in the field. The winners will be...
Comprehensive Urology Studies ED Injections with Shockwave Therapy for Penile Girth Enhancement
23. September 2024 15:34 ET
|
Comprehensive Urology
Comprehensive Urology of Los Angeles studies STUD Protocol for male enhancement in survivors of prostate cancer during Prostate Cancer Awareness Month.
Curium: Erste Kommerzielle Dosen von PYLCLARI® in Deutschland Verfügbar - Ein Innovativer 18f-PSMA PET Tracer für Patienten Mit Prostatakrebs
06. Mai 2024 04:25 ET
|
Curium
PARIS, May 06, 2024 (GLOBE NEWSWIRE) -- Curium, ein weltweit führendes Unternehmen der Nuklearmedizin, gab heute bekannt, dass in München und Nürnberg die ersten kommerziellen Dosen von PYLCLARI®...
Curium Announces First Commercial Doses in Germany of PYLCLARI® – An Innovative 18F-PSMA PET Tracer Indicated in Patients With Prostate Cancer
06. Mai 2024 04:25 ET
|
Curium
Curium announced that today in Munich and Nurnberg, Germany the first commercial doses of PYLCLARI® have been delivered.
CURIUM ANNUNCIA LE PRIME DOSI COMMERCIALI IN ITALIA DI PYLCLARI® - UN INNOVATIVO TRACCIANTE PET 18F-PSMA INDICATO NEI PAZIENTI CON TUMORE ALLA PROSTATA
07. März 2024 08:51 ET
|
Curium
Parigi, Francia, March 07, 2024 (GLOBE NEWSWIRE) -- Curium, leader mondiale nella medicina nucleare, ha annunciato oggi la vendita delle prime dosi commerciali di PYLCLARI® in Italia. PYLCLARI®...
Curium Announces First Commercial Doses in Italy of PYLCLARI® – An Innovative 18F-PSMA PET Tracer Indicated in Patients With Prostate Cancer
07. März 2024 08:51 ET
|
Curium
PARIS, March 07, 2024 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today that the first commercial doses of PYLCLARI® have been sold in Italy. PYLCLARI® (INN:...
Curium Announces Submission of the Marketing Authorization Application for PYLCLARI®, an Innovative (18F)-PSMA PET Tracer Indicated in Adults With Prostate Cancer to Swissmedic
22. Februar 2024 06:19 ET
|
Curium
PARIS, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today that the marketing authorization application for PYLCLARI® (INN: Piflufolastat (18F) formerly...
US Urologists Industry Report 2023: Five-Year Forecasts and Key Player Analysis
01. November 2023 09:13 ET
|
Research and Markets
Dublin, Nov. 01, 2023 (GLOBE NEWSWIRE) -- The "Urologists in the US - Industry Market Research Report" has been added to ResearchAndMarkets.com's offering. This report offers valuable insights...
Urinary Tract Infection Testing Market to hit USD 1 billion by 2032, says Global Market Insights Inc.
29. Oktober 2023 09:51 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Oct. 29, 2023 (GLOBE NEWSWIRE) -- Urinary Tract Infection Testing Market size is expected to be worth USD 1 billion by 2032. According to the study, industry increase is driven...
Outlook on the Urinary Tract Infection Testing Global Market to 2030 - Featuring Accelerate Diagnostics, Bio-Rad Laboratories and Danaher Among Others
30. August 2022 08:33 ET
|
Research and Markets
Dublin, Aug. 30, 2022 (GLOBE NEWSWIRE) -- The "Global Urinary Tract Infection Testing Market Size, Share & Trends Analysis by Type (Urethritis, Cystitis, Pyelonephritis), by End-Use (Reference...